Search by Drug Name or NDC
NDC 46122-0603-05 GNP EyeDrops Maximum Redness Relief .5; .03 g/100mL; g/100mL Details
GNP EyeDrops Maximum Redness Relief .5; .03 g/100mL; g/100mL
GNP EyeDrops Maximum Redness Relief is a OPHTHALMIC SOLUTION in the HUMAN OTC DRUG category. It is labeled and distributed by AmerisourceBergen. The primary component is GLYCERIN; NAPHAZOLINE HYDROCHLORIDE.
Product Information
| NDC | 46122-0603 |
|---|---|
| Product ID | 46122-603_0d291a5f-b635-380c-e063-6394a90a0310 |
| Associated GPIs | 86409902072040 |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | GNP EyeDrops Maximum Redness Relief |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | glycerin, naphazoline HCl |
| Product Type | HUMAN OTC DRUG |
| Dosage Form | SOLUTION |
| Route | OPHTHALMIC |
| Active Ingredient Strength | .5; .03 |
| Active Ingredient Units | g/100mL; g/100mL |
| Substance Name | GLYCERIN; NAPHAZOLINE HYDROCHLORIDE |
| Labeler Name | AmerisourceBergen |
| Pharmaceutical Class | Allergens [CS], Cell-mediated Immunity [PE], Glycerol [CS], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Chemical Allergen [EPC] |
| DEA Schedule | n/a |
| Marketing Category | OTC MONOGRAPH DRUG |
| Application Number | M018 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 46122-0603-05 (46122060305)
| NDC Package Code | 46122-603-05 |
|---|---|
| Billing NDC | 46122060305 |
| Package | 1 BOTTLE, DROPPER in 1 CARTON (46122-603-05) / 15 mL in 1 BOTTLE, DROPPER |
| Marketing Start Date | 2019-09-05 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |